NCT06154577

Brief Summary

Hypoglossal nerve stimulation (HNS) plays an increasingly important role in managing patients with obstructive sleep apnea (OSA) who do not tolerate CPAP therapy and are not eligible for other alternative treatment options, such as mandibular advancement devices or positional therapy. The posterior upper airway space dimensions are crucial in managing patients with HNS in the patient selection process and therapy control. The lateral collapse of the upper airway is of crucial importance. Lateral collapse at the palatal level and of the oropharyngeal walls is a well-established negative predictive factor for therapeutic success. Patients with complete concentric collapse at the palatal level (pCCC) in drug-induced sedation endoscopy (DISE) must be excluded from the implantation of HNS, which is cumbersome and invasive. Endoscopy has the inherent limitation that only one level can be observed at a given time, and assessment is possibly hampered by phlegm. During activation and titration of HNS, tongue protrusion is observed in the awake patient. However, this method does not allow for assessing the opening of the retroglossal (RG) and retropalatal (RP) airway space, which is the ultimate therapeutic goal. Insufficient opening of the airway is the reason for non-responders with HNS. Insufficient upper airway opening can be either at the retropalatal or retroglossal level. The study aims to identify insufficient airway openings better using sub-mental ultrasonography. Sub-mental standardized and orientated ultrasonography offers a quantitative, reproducible way of assessing transverse upper airway dimensions and anatomic features of the upper airway in a rapid and non-invasive manner. In addition, anatomic characteristics of the airway's adjacent tissue, such as the size and shape of the tongue, may also have an impact on the effectiveness of HNS. Tongue morphology and posterior airway space assessment could be used in preoperative evaluation and during therapeutic titration of HNS. The clinical routine could be included tongue morphology and posterior airway space assessment without additional patient risks. However, the clinical value of assessing posterior airway space and tongue morphology in patients with HNS is yet unknown.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 4, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2024

Completed
Last Updated

June 5, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

November 16, 2023

Last Update Submit

June 4, 2024

Conditions

Keywords

hypoglossal nerve stimulationultrasonography

Outcome Measures

Primary Outcomes (1)

  • Prediction of therapeutic success with hypoglossal nerve stimulation

    Success is defined as apnea-hypopnea index in the most recent sleep testing ≤ 20/h and 50% reduction from baseline

    Most recent sleep testing before examination after HNS implantation, a maximum of 6 months before examination

Secondary Outcomes (6)

  • Prediction of AHI reduction, defined as the difference between pre- and postoperative AHI, with HNS based on tongue morphology and posterior airway space.

    Most recent sleep testing before examination after HNS implantation, a maximum of 6 months before examination

  • Comparison of pharyngeal dimensions between visual assessment and tongue morphology and posterior airway space

    through study completion, from 15.05.2023 to 14.05.2024

  • Therapeutical guidance using tongue morphology and posterior airway space to identify the obstructing upper airway segment compared to wake fiberoptic endoscopy during HGS in non-responders.

    through study completion, from 15.05.2023 to 14.05.2024

  • Patient comfort rated by the patients for wake transnasal endoscopy and sub-mental ultrasonography

    through study completion, from 15.05.2023 to 14.05.2024

  • Information gain through from tongue morphology and posterior airway space imaging

    through study completion, from 15.05.2023 to 14.05.2024

  • +1 more secondary outcomes

Study Arms (2)

Obstructive sleep apnea patients

39 obstructive sleep apnea patients with hypoglossal nerve stimulation

Diagnostic Test: Ultrasonography

Healthy controls

15 healthy control participants

Diagnostic Test: Ultrasonography

Interventions

UltrasonographyDIAGNOSTIC_TEST

Assessment of tongue morphology and posterior airway space using ultrasonography (AmCAD-UO, CE mark NB1639)

Healthy controlsObstructive sleep apnea patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

39 obstructive sleep apnea patients with hypoglossal nerve stimulation and 15 subjects in the control group

You may qualify if:

  • Patients older than 18 year
  • patients with a hypoglossal nerve implantation
  • control group: 15 subjects without OSA (AHI\<10/h)
  • written informed consent
  • sufficient knowledge of German or French to understand informed consent

You may not qualify if:

  • Patients younger than 18 years
  • unwillingness to give informed consent
  • incapable of performing Müller's maneuver
  • history of head and neck surgery other than HNS, tonsillectomy, and maxillomandibular advancement
  • diagnosis of congestive heart failure or chronic pulmonary disease
  • diagnosis of co-morbid sleep disorders, including central sleep apnea
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kantonsspital Baselland

Liestal, Basel-Landschaft, 4410, Switzerland

Location

University Hospital Bern, Inselspital

Bern, 3010, Switzerland

Location

Related Publications (1)

  • Tschopp S, Janjic V, Lee Y, Chen A, Chao PY, Caversaccio M, Borner U, Tschopp K. Backscattered Ultrasonographic Imaging of the Tongue and Outcome in Hypoglossal Nerve Stimulation. Otolaryngol Head Neck Surg. 2025 Jun;172(6):2134-2140. doi: 10.1002/ohn.1251. Epub 2025 Apr 7.

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea Syndromes

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2023

First Posted

December 4, 2023

Study Start

May 15, 2023

Primary Completion

May 29, 2024

Study Completion

May 29, 2024

Last Updated

June 5, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations